Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells
- PMID: 8806513
- DOI: 10.1006/viro.1996.0424
Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells
Abstract
The antigen specificity of HCMV-specific cytotoxic T cells (CTL) was investigated in healthy adult seropositive donors by analyzing the frequency of CTL precursors (CTLp) against six different HCMV-encoded proteins. HCMV-specific, CD8+ CTL clones from two donors were also characterized. Thje precursor frequency analysis showed that a major phosphoprotein of HCMV, pp65 (UL83), was the immunodominant CTL target antigen in healthy seropositive adults. The frequency of CTLp specific for different HCMV proteins ranged from 1/12,000 for pp65 to > 1/100,000 for gB (UL55), gH (UL75), pp50 (UL44), and pp28 (UL98). Characterization of the HCMV-specific CTL clones from two donors revealed that the majority of clones lysed targets expressing pp65 and that none of the clones recognized other HCMV proteins.
Similar articles
-
Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.J Infect Dis. 2000 May;181(5):1537-46. doi: 10.1086/315445. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823751
-
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.J Virol. 1996 Nov;70(11):7569-79. doi: 10.1128/JVI.70.11.7569-7579.1996. J Virol. 1996. PMID: 8892876 Free PMC article.
-
Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.Virology. 2002 Apr 10;295(2):208-16. doi: 10.1006/viro.2001.1335. Virology. 2002. PMID: 12033779
-
Adoptive immunotherapy of HCMV infection.Cytotherapy. 2007;9(8):699-711. doi: 10.1080/14653240701656046. Epub 2007 Oct 4. Cytotherapy. 2007. PMID: 17917875 Review.
-
[Mechanisms in evasion of host immune response by HCMV].Nihon Rinsho. 2006 Mar;64 Suppl 3:421-6. Nihon Rinsho. 2006. PMID: 16615508 Review. Japanese. No abstract available.
Cited by
-
Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.PLoS Pathog. 2023 Nov 16;19(11):e1011643. doi: 10.1371/journal.ppat.1011643. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 37972198 Free PMC article.
-
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.Biol Blood Marrow Transplant. 2015 Sep;21(9):1663-78. doi: 10.1016/j.bbmt.2015.05.015. Epub 2015 May 29. Biol Blood Marrow Transplant. 2015. PMID: 26028505 Free PMC article. Clinical Trial.
-
DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells.PLoS Pathog. 2024 Sep 26;20(9):e1012581. doi: 10.1371/journal.ppat.1012581. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39325839 Free PMC article.
-
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV.Viruses. 2019 Dec 28;12(1):35. doi: 10.3390/v12010035. Viruses. 2019. PMID: 31905677 Free PMC article. Review.
-
A bipartite trigger for dislocation directs the proteasomal degradation of an endoplasmic reticulum membrane glycoprotein.J Biol Chem. 2008 Feb 15;283(7):4031-43. doi: 10.1074/jbc.M706283200. Epub 2007 Dec 17. J Biol Chem. 2008. PMID: 18086679 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
